INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 66 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q4 2016. The put-call ratio across all filers is 21.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,000 | +100.0% | 2,095 | +61.8% | 0.00% | – |
| Q4 2017 | $1,000 | -50.0% | 1,295 | +18.3% | 0.00% | – |
| Q3 2017 | $2,000 | -95.7% | 1,095 | -93.8% | 0.00% | – |
| Q2 2017 | $47,000 | -50.0% | 17,713 | -23.7% | 0.00% | – |
| Q1 2017 | $94,000 | -17.5% | 23,213 | -14.1% | 0.00% | – |
| Q4 2016 | $114,000 | +48.1% | 27,018 | +139.4% | 0.00% | – |
| Q3 2016 | $77,000 | +67.4% | 11,288 | +42.6% | 0.00% | – |
| Q2 2016 | $46,000 | -43.2% | 7,917 | -31.0% | 0.00% | – |
| Q1 2016 | $81,000 | +44.6% | 11,470 | +48.7% | 0.00% | – |
| Q4 2015 | $56,000 | -17.6% | 7,712 | -2.3% | 0.00% | – |
| Q3 2015 | $68,000 | +172.0% | 7,890 | +387.6% | 0.00% | – |
| Q2 2015 | $25,000 | – | 1,618 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|